Nanobiosym hired the agency shortly after its proprietary technology was approved by the FDA.
MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.
Plan D: Experts predict government savings, but higher co-pays with Trump plan for lowering drug prices
The White House's strategy calls for moving expensive treatments from under Medicare Part B to Medicare Part D.
Insys founder John Kapoor has maintained his innocence in the face of charges.
Accenture has taken another big step into the agency space by launching a programmatic media planning and buying unit.
Keytruda passes late-stage trial; Astellas to cut 600 jobs in restructuring; Teva expects FDA decision on migraine drug by mid-September.
Geisinger looks to expand DNA sequencing program; Celgene invests $65 million more in Evotec; Oscar launches transparency push.
The Beating Cancer Is in Our Blood brand positioning was developed with Oberland.
FDA approves AstraZeneca potassium drug; Nabriva pneumonia treatment meets Phase III endpoints; "Bad Blood" hits bookshelves.
MM&M is honoring 20 Women to Watch, aspiring healthcare commercial and marketing execs changing the face of the industry.
First preventative migraine treatment approved; NIH investigates funding for alcohol study; Trump to block federal funding for abortion clinics.
Shaun Qualheim from Amazon Web Services explained how the company's small teams and customer-first and failure-friendly culture promotes innovation.
Experts on using technology to change patient behavior and other topics.